Should I Buy PHBBF Stock in 2026?
Data-driven analysis and honest assessment for Pharmaron Beijing Co., Ltd.
Current Price: $0.00P/E: 16.1
Decision Score
Hold
Based on 6 fundamental factors
Score Breakdown:
Reasonable P/E of 16.1
Growth data limited
Profitability data limited
Financial health data limited
Cash flow data limited
No recent insider activity
Key Investment Metrics
Current Price
$0.00
P/E Ratio
16.08
Revenue Growth
N/A
Profit Margin
N/A
Market Cap
$4.7B
Dividend Yield
10.36%
How PHBBF Compares to Competitors
Understanding how PHBBF stacks up against peers helps inform your investment decision.
How PHBBF Compares to Peers
Upcoming Events for PHBBF
+5 Reasons TO Buy PHBBF
1. Attractive dividend yield of 10.4%
strongDividend yield above 3% provides meaningful income and signals management confidence.
-5 Reasons NOT to Buy PHBBF
1. Minimal revenue growth
low riskGrowth of 0.0% barely keeps pace with inflation.
Who Should Buy PHBBF?
Investment Profile
Risk Level
High
Recommended Holding Period
1-3 years or long-term income
Best For:
- ✓
Income Investors
10.4% yield provides regular income
Not Suitable For:
- ✗
Growth Investors
Limited 0% growth may disappoint
- ✗
Risk-Averse Investors
High risk may cause uncomfortable volatility
- ✗
Large Position Traders
Lower liquidity may impact execution
Consider These Alternatives
If you're interested in PHBBF, compare these Healthcare peers:
Pro tip: Compare PHBBF directly with competitors using our comparison tool to see which stock better fits your criteria.
Get the Full Picture
Access AI-powered insights, DCF valuations, insider trading data, and real-time analysis for PHBBF
Frequently Asked Questions
What is PHBBF stock price today?
Visit our real-time dashboard for the current PHBBF stock price and live market data.
Is PHBBF stock going up or down today?
PHBBF stock price movements are influenced by market conditions, news, earnings reports, and investor sentiment. Check our live dashboard for real-time price changes and technical indicators.
Should I buy PHBBF stock now?
The decision to buy PHBBF depends on your investment strategy, risk tolerance, and financial goals. Our AI analysis evaluates fundamentals, valuation metrics, growth prospects, and market conditions to help inform your decision.
Is PHBBF a buy, hold, or sell right now?
Our AI-powered analysis provides buy/hold/sell recommendations for PHBBF based on multiple factors including valuation, growth metrics, technical indicators, and analyst consensus. Visit our dashboard for the latest recommendation.
Is PHBBF stock overvalued or undervalued?
PHBBF currently trades at a P/E ratio of 16.08 relative to earnings. Our DCF calculator provides intrinsic value estimates to help determine if PHBBF is fairly priced.
What is PHBBF's P/E ratio?
PHBBF has a price-to-earnings (P/E) ratio of 16.08, which measures how much investors are willing to pay per dollar of earnings. Compare this to industry peers and historical averages for context.
What is PHBBF's market cap?
PHBBF (Pharmaron Beijing Co., Ltd.) has a market capitalization of $4.70 billion, making it a small-cap stock.
What is PHBBF's price to book ratio?
Price-to-book ratio for PHBBF is available on our dashboard along with other valuation metrics.
Deep Dive Analysis
Explore comprehensive analysis tools to make an informed decision about Pharmaron Beijing Co., Ltd.
Full Stock Analysis
Complete PHBBF overview with charts and data
Is PHBBF Undervalued?
DCF valuation and intrinsic value analysis
Dividend Analysis
Yield, payout ratio, and dividend history
Growth Analysis
Revenue, earnings, and expansion metrics
Financial Health
Debt, liquidity, and balance sheet strength
Price Prediction
2026 forecast and price targets
Stock Forecast
12-month price forecast and analyst targets
Earnings Date
Next earnings date and historical results
Compare Before You Buy
See how PHBBF stacks up against its competitors
Similar Investment Decisions
Explore investment analyses for stocks similar to Pharmaron Beijing Co., Ltd.
Complete PHBBF Analysis
Compare PHBBF With
Disclaimer
This analysis is for informational purposes only and should not be considered financial advice. The decision score and recommendations are based on quantitative factors and do not account for all risks, your personal financial situation, or qualitative factors. Always do your own research and consider consulting with a financial advisor before making investment decisions.